Krystal Biotech
KRYS
KRYS
90 hedge funds and large institutions have $502M invested in Krystal Biotech in 2020 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 35 increasing their positions, 28 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
90
Holders Change
–
Holders Change %
0%
% of All Funds
1.99%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.04%
New
14
Increased
35
Reduced
28
Closed
12
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
CCM
Consonance Capital Management
New York
|
+$19.5M |
| 2 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$13M |
| 3 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$10.8M |
| 4 |
CWG
C WorldWide Group
Copenhagen,
Denmark
|
+$5.87M |
| 5 |
Aviva
London,
United Kingdom
|
+$4.02M |
Top Sellers
| 1 |
O
OrbiMed
New York
|
-$55.1M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$6.82M |
| 3 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$4.78M |
| 4 |
BBA
Baker Bros. Advisors
New York
|
-$3.81M |
| 5 |
ACM
Atika Capital Management
New York
|
-$3.23M |
